You are viewing: US Pet Biotics Market analysis
Part of: Pet Biotics Market (Global)

The US Pet Biotics Market was valued at $285 Million in 2025 and projected to reach to $399.1 Million by 2030, representing a compound annual growth rate of 7.0%. The US pet biotics market is positioned for sustained expansion through 2030, fueled by growing consumer education around gut health benefits for pets and increasing veterinary endorsements of probiotic supplementation.

US Pet Biotics Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Pet Biotics Market Trends and Insights

  • The US market is driven by increasing pet owner awareness of digestive health and preventive wellness, with probiotics and prebiotics becoming mainstream pet care categories.
  • In the US, the shift toward premium and functional pet foods reflects broader consumer trends favoring natural and science-backed nutritional solutions for companion animals. The US pet biotics sector benefits from strong veterinary endorsement and growing e-commerce distribution channels that make these products more accessible to pet owners nationwide.
  • By 2030, the US market is expected to capture significant share as pet humanization trends continue and owners invest more in preventive health measures.
  • The US competitive landscape includes both established pet nutrition companies and emerging biotech firms developing targeted probiotic formulations for specific pet health conditions..

Key Market Statistics

  • CAGR (2025-2030) 7.0% CAGR
  • Market Size, 2025 ~USD 285 Million
  • Forecast, 2030 ~USD 399.1 Million
  • Country US

US Pet Biotics Market Overview

Market Size & Growth :

The US pet biotics market reached $285.0 million in 2025 and is projected to grow to $399.1 million by 2030, representing a steady 7% CAGR driven by premiumization of pet care products.

Consumer Awareness Surge :

US pet owners are increasingly prioritizing digestive health and preventive wellness for their pets, with probiotics and prebiotics transitioning from niche supplements to mainstream pet care staples.

Premium Product Demand :

The shift toward premium and functional pet foods in the US reflects evolving consumer preferences for scientifically-backed, health-focused pet nutrition solutions that address specific wellness needs.

Preventive Health Trend :

US pet owners are investing in preventive care solutions, with pet biotics gaining traction as essential components of comprehensive pet wellness routines alongside traditional veterinary care.

US Pet Biotics Market Dynamics

  • Pet owners in the US are demonstrating willingness to invest in premium wellness products, creating opportunities for differentiated formulations targeting specific pet health concerns.
  • The market will likely see continued innovation in delivery formats, ingredient sourcing, and clinical substantiation as competition intensifies among established pet food manufacturers and emerging biotech companies..

Related Ecosystem

Fandb Additives

Top Technologies
  • Dairy Products
  • Bakery Products
  • Polyglycerol Esters
  • Microorganism
  • Carbohydrates
Top Companies
  • AZELIS HOLDINGS SA
  • Archer-Daniels-Midland Company
  • Amway
  • UNILEVER PLC
  • DuPont de Nemours, Inc.

    Key Takeaways

    • The US pet biotics market will grow from $285.0M (2025) to $399.1M (2030) at a 7.0% CAGR.
    • Pet humanization and preventive health awareness are primary growth drivers in the US market.
    • The US benefits from strong veterinary support and expanding e-commerce distribution networks.
    • By 2030, the US market will see increased competition from both established and emerging biotech players.

    Pet Biotics Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment ORAL & DENTAL HEALTH (Function)
    Forecast Period 2025–2030
    Growth Rate CAGR of 6.9% from 2025 to 2030
    Largest Segment DRY (Form)
    Market Size Base Year (Billions) ~USD 0.88 (2025)
    Revenue Forecast (Billions) ~USD 1.23 (2030)
    Segments Covered Type, Subtype, Application, Form, Pet, Function

    US Pet Biotics Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Type

    • Bacteria
    • Bifidobacterium
    • Fos
    • Gos
    • Inulin
    • Lactobacillus
    • Mos
    • Oligosaccharides
    • Other Bacteria
    • Other Prebiotic Types
    • Polydextrose
    • Postbiotics
    • Prebiotics
    • Probiotics
    • Saccharomyces Boulardii
    • Saccharomyces Cerevisiae
    • Yeast & Fungi

    By Subtype

    • Bacillus
    • Bifidobacterium
    • Enterococcus
    • Lactobacillus
    • Streptococcus Thermophilus

    By Application

    • Dry Food
    • Snacks & Treats
    • Supplements
    • Wet Food

    By Form

    • Dry
    • Liquid

    By Pet

    • Cats
    • Dogs
    • Other Pets

    By Function

    • Digestive/Gut Health
    • Immune Modulation
    • Metabolic & Weight Management
    • Oral & Dental Health
    • Other Functions

    Target Audience

    • Pet Food Manufacturers : Need US market data to develop probiotic-enriched pet food lines, understand consumer demand drivers, and position products competitively in the growing functional pet nutrition category.
    • Pet Supplement Companies : Require detailed US market insights to identify growth opportunities, optimize product formulations for American pet owners, and develop targeted go-to-market strategies for probiotic supplements.
    • Veterinary Professionals : Seek evidence-based market information to recommend appropriate probiotic solutions to US pet owners, understand product availability, and stay informed on emerging wellness trends in pet care.
    • Retail & Distribution Partners : Need US market forecasts and consumer behavior data to optimize shelf space allocation, negotiate supplier terms, and capitalize on the growing demand for pet biotics in retail channels.
    • Investment & Private Equity Firms : Require comprehensive US market analysis to evaluate investment opportunities in pet biotech companies, assess market growth potential, and identify acquisition targets in the pet wellness space.

    Key Companies in the US Pet Biotics Market

    CompanyHQOwnershipStrongest segments
    ADMUnited StatesPublic CompanyAg Services and Oilseeds,Carbohydrate Solutions,Nutrition,
    KERRY GROUP PLCIrelandPublic CompanyTaste solutions (flavours, extracts, modulations),Nutrition solutions (enzymes, proteins, lipids, fibre, wellness),Functional ingredients, food and beverage solutions,
    DSM-FIRMENICHSwitzerlandPublic CompanyPerfumery & Beauty,Taste, Texture & Health,Health, Nutrition & Care,
    CARGILL, INCORPORATEDUnited StatesPrivate CompanyGrains & Oilseeds Origination, Trading, and Processing,Animal Nutrition & Protein (Livestock, Aquaculture, Meat, Poultry),Food & Beverage Ingredients and Foodservice/Retail Solutions,
    PROBISwedenPrivate CompanyDietary supplement probiotics (capsules, tablets, chewables, powders),Food and beverage probiotics (drinks, shots, carbonated, dairy, plant-based, frozen desserts),Specialized formulations (children’s, oral, bone, iron-absorption, recovery drinks, powder formulas),
    PHILEO BY LESAFFREFranceSubsidiaryYeast-based functional additives (MOS, ß-glucans, yeast cell walls, inactivated yeasts),Probiotics, live bacteria, and direct-fed microbials,Postbiotics and fermentation-derived metabolites,

    ADM

    ADM (Archer Daniels Midland Company) is a publicly traded American agricultural processor and food ingredient company founded in 1902. With 41,147 employees, ADM operates globally in grain processing, oilseed crushing, and ingredient manufacturing.

    KERRY GROUP PLC

    Kerry Group PLC is a publicly traded Irish food and beverage ingredients company founded in 1972. With 19,284 employees, the company specializes in taste and nutrition solutions for the food industry.

    DSM-FIRMENICH

    DSM-Firmenich is a publicly traded Swiss company founded in 1902 with 26,873 employees, specializing in nutrition, health, and beauty ingredients. The company serves the food, beverage, dietary supplement, and personal care industries.

    CARGILL, INCORPORATED

    Cargill, Incorporated is a privately held American agricultural and food processing company founded in 1865. With 155,000 employees, Cargill is one of the world's largest privately held corporations, operating in grain trading, livestock, and food ingredient production.

    PROBI

    Probi is a Swedish private company founded in 1991 with 157 employees, specializing in probiotic products and dietary supplements. The company focuses on developing and commercializing probiotic-based health solutions.

    PHILEO BY LESAFFRE

    Phileo by Lesaffre is a subsidiary company founded in France in 2011, specializing in microbial solutions and probiotics for animal nutrition and health.

    Reasons to Buy this Report

    • Market Size Validation : Access precise US market valuation ($285M in 2025) and 5-year forecast data to benchmark competitive positioning and identify revenue opportunities in the rapidly expanding pet biotics segment.
    • Consumer Behavior Insights : Understand US pet owner preferences for preventive wellness and premium products, enabling targeted product development and marketing strategies aligned with demonstrated purchasing patterns.
    • Growth Trajectory Analysis : Leverage the 7% CAGR projection to model expansion scenarios, allocate R&D budgets, and plan market entry or expansion strategies with confidence in market fundamentals.
    • Competitive Landscape Intelligence : Identify market dynamics driving premiumization in US pet care, assess competitive threats from functional pet food manufacturers, and discover white-space opportunities in underserved segments.
    • Strategic Decision Support : Make informed decisions on product portfolio expansion, distribution channel optimization, and partnership opportunities based on comprehensive US market data and forward-looking projections.

    Frequently asked questions

    What is the current size of the US pet biotics market?

    The US pet biotics market is valued at $285.0 million in 2025 and is expected to reach $399.1 million by 2030.

    What is the growth rate of the US pet biotics market?

    The US pet biotics market is projected to grow at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2030.

    What drives growth in the US pet biotics market?

    Growth in the US market is driven by increasing pet owner awareness of digestive health, pet humanization trends, veterinary endorsement, and the availability of premium functional pet foods.

    How is the US pet biotics market distributed?

    The US pet biotics market is distributed through veterinary clinics, pet specialty retailers, e-commerce platforms, and mainstream pet food channels, with e-commerce showing rapid expansion.

    Who are the key competitors in the US pet biotics market?

    The US market includes established pet nutrition companies, major pet food manufacturers, and emerging biotech firms developing specialized probiotic formulations for companion animals.

    RESEARCH METHODOLOGY

    This study employed two primary approaches to estimate the current size of the pet biotics market. Exhaustive secondary research was conducted to gather information on the type, application, pet, form, function, and manufacturing technology segments of the market (qualitative). The next step involved validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, data triangulation was used to estimate the market size of segments and subsegments.

    Secondary Research

    This research study utilized extensive secondary sources, including directories and databases such as Bloomberg Businessweek and Factiva, to identify and collect information for a technical, market-oriented, and commercial market study. In the secondary research process, sources such as annual reports, press releases & investor presentations of companies, white papers, pet food journals, certified publications, articles from recognized authors, directories, and databases were referred to identify and collect information. Secondary research was mainly used to obtain key information about the industry’s supply chain, the pool of key players, and market classification and segmentation based on the industry trends to the bottom-most level, regional markets, and key developments from market- and technology-oriented perspectives.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the pet biotics market scenario through secondary research. Several primary interviews were conducted with market experts from the demand and supply sides across major countries of North America, Europe, Asia Pacific, South America, and the Rest of the World. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief Experience Officers (CXOs), vice presidents (VPs), directors from business development, marketing, research, and development teams, as well as key executives from distributors and key opinion leaders.

    Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped to understand the various trends related to type, application, pet, form, functions, and manufacturing technology (qualitative), as well as region. Stakeholders from the demand side, including distributors, importers, exporters, and end-use sectors such as pet food and pet supplement manufacturers, were interviewed to gain insight into the buyers’ perspective on suppliers, products, and the outlook for their businesses, which will impact the overall market.

    Pet Biotics Market
 Size, and Share

    The three tiers of the companies are defined based on their total revenues in 2023 or 2024, based on the availability of financial data: Tier 1: Revenue > USD 1 billion; Tier 2: USD 100 million ≤ revenue ≤ USD 1 billion; Tier 3: Revenue < USD 100 million.

    RoW includes Africa and the Middle East.

    COMPANY NAME

    DESIGNATION

    Cargill, Incorporated (US)

    Product Development Manager

    Bharat International Pet Foods Pvt. Ltd. (Manager)

    Sales Manager

    Purina Animal Nutrition LLC (US)

    Marketing Head

    BIOPROX (France)

    Marketing Head

    Alltech (US)

    Senior Sales Manager

    Kemin Industries, Inc. (US)

    Business Development Manager

     

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The top-down and bottom-up approaches were used to estimate and validate the total size of the pet biotics market. These approaches were also used extensively to determine the size of various market segments. The research methodology used to estimate the market size includes the following details:

    • The key players in the industry and the overall markets were identified through extensive secondary research.
    • All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
    • All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.
    • The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.

    Pet Biotics Market : Top-Down and Bottom-Up Approach

    Pet Biotics Market  Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to estimate the overall pet biotics market and obtain precise statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using the top-down and bottom-up approaches.

    Market Definition

    Pet biotics refer to a group of functional ingredients, including probiotics, prebiotics, and postbiotics, that are incorporated into pet foods, treats, toppers, and nutritional supplements to support gut health, digestion, immunity, nutrient absorption, and overall well-being. Probiotics are live beneficial microorganisms, prebiotics are non-digestible fibers that selectively nourish these beneficial microbes, and postbiotics are bioactive compounds produced through microbial fermentation. Together, these ingredients help maintain a balanced gut microbiome and enhance the health and performance of pets.

    Key Stakeholders

    • Probiotic strain manufacturers
    • Prebiotics & postbiotics ingredient manufacturers
    • Pet food and supplement product manufacturers
    • Key companies engaged in pet food processing
    • Intermediate stakeholders, including distributors, retailers, associations, regulatory bodies, and others
    • Government organizations, institutes, and research organizations
    • Associations and industry bodies:
      • Pet Food Institute (PFI)
      • International Probiotics Association (IPA)
      • International Scientific Association for Probiotics and Prebiotics (ISAPP)
      • European Food Safety Authority (EFSA)
      • American Pet Products Association
      • Global Alliance of Pet Food Associations
      • The European Pet Organization
      • Association of American Feed Control Officials (AAFCO)
      • American Veterinary Medical Association (AVMA)

    Report Objectives

    • To determine and project the size of the pet biotics market based on type, application, pet, form, function, manufacturing technology (qualitative), and region, over five years, ranging from 2025 to 2030
    • To identify the attractive opportunities in the market by determining the largest and fastest-growing segments across regions
    • To provide detailed information about the key factors influencing market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To analyze the micromarkets with respect to individual growth trends, prospects, and their contribution to the total market
    • To identify and profile the key players in the market
    • To understand the competitive landscape and identify the major growth strategies adopted by players across the key regions

    Customization Options

    With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs. The following customization options are available for the report:

    Product Analysis

    • Product matrix, which provides a detailed comparison of each company's product portfolio.

    Geographic Analysis

    With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

    • Further breakdown of the Rest of European pet biotics market into key countries
    • Further breakdown of the Rest of Asia Pacific pet biotics market into key countries
    • Further breakdown of the Rest of South American pet biotics market into key countries

    Company Information

    • Detailed analyses and profiling of additional market players (up to five)

     

     

    Get the Full Pet Biotics Market Report

    Full forecast, segment splits, and company analysis for all Pet Biotics Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status